Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used

Heleen Demeyer, Elena Gimeno-Santos, Roberto A Rabinovich, Miek Hornikx, Zafeiris Louvaris, Willem I de Boer, Niklas Karlsson, Corina de Jong, Thys Van der Molen, Ioannis Vogiatzis, Wim Janssens, Judith Garcia-Aymerich, Thierry Troosters, Michael I Polkey, PROactive consortium, Heleen Demeyer, Elena Gimeno-Santos, Roberto A Rabinovich, Miek Hornikx, Zafeiris Louvaris, Willem I de Boer, Niklas Karlsson, Corina de Jong, Thys Van der Molen, Ioannis Vogiatzis, Wim Janssens, Judith Garcia-Aymerich, Thierry Troosters, Michael I Polkey, PROactive consortium

Abstract

Background: The GOLD multidimensional classification of COPD severity combines the exacerbation risk with the symptom experience, for which 3 different questionnaires are permitted. This study investigated differences in physical activity (PA) in the different GOLD quadrants and patient's distribution in relation to the questionnaire used.

Methods: 136 COPD patients (58±21% FEV1 predicted, 34F/102M) completed COPD assessment test (CAT), clinical COPD questionnaire (CCQ) and modified Medical Research Council (mMRC) questionnaire. Exacerbation history, spirometry and 6MWD were collected. PA was objectively measured for 2 periods of 1 week, 6 months apart, in 5 European centres; to minimise seasonal and clinical variation the average of these two periods was used for analysis.

Results: GOLD quadrants C+D had reduced PA compared with A+B (3824 [2976] vs. 5508 [4671] steps.d-1, p<0.0001). The choice of questionnaire yielded different patient distributions (agreement mMRC-CAT κ = 0.57; CCQ-mMRC κ = 0.71; CCQ-CAT κ = 0.72) with different clinical characteristics. PA was notably lower in patients with an mMRC score ≥2 (3430 [2537] vs. 5443 [3776] steps.d-1, p <0.001) in both the low and high risk quadrants.

Conclusions: Using different questionnaires changes the patient distribution and results in different clinical characteristics. Therefore, standardization of the questionnaire used for classification is critical to allow comparison of different studies using this as an entry criterion.

Clinical trial registration: ClinicalTrials.gov NCT01388218.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist. The funding of the present work does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1. The new GOLD assessment.
Fig 1. The new GOLD assessment.
The classification combines the symptomatic assessment with the patients’ spirometric classification and/or risk of exacerbations, resulting in 4 quadrants. To classify patients first symptoms should be assessed with the mMRC, CAT or CCQ scale and investigator should determine if the patient belongs to the left (less symptoms) or right (more symptoms) side of the box. Next the risk of exacerbations should be assessed to determine if the patient belongs to the lower part of the box (low risk) or the upper part of the box (higher risk). When assessing symptoms the mMRC, CAT or the CCQ scale can be used; when assessing risk the highest risk according to GOLD grade or exacerbation history should be chosen.
Fig 2. Physical activity across different GOLD…
Fig 2. Physical activity across different GOLD classifications.
GOLD = Spirometric GOLD classification; mMRC = combined assessment using mMRC; CAT = combined assessment using CAT; CCQ = combined assessment using CCQ; Significant differences (post hoc analysis) are indicated with a solid line.
Fig 3. Physical activity across different mMRC,…
Fig 3. Physical activity across different mMRC, CAT and CCQ cut-offs.
Upper panels present physical activity data, significant differences (post hoc analysis) are indicated with a solid line; lower panels depict proportion of patients defined as sedentary (black bars). Dotted line present cut off used in the GOLD classification; A/C and B/D indicate respectively quadrants A or C and B or D.
Fig 4. Patient distribution across the different…
Fig 4. Patient distribution across the different GOLD classifications.
The size of the squares represent the patient distribution relative to quadrant A. mMRC = combined assessment using mMRC; CAT = combined assessment using CAT; CCQ = combined assessment using CCQ.

References

    1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med.2013;187(4): 347–365. 10.1164/rccm.201204-0596PP
    1. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014 Available from: .; 25-3-2014.
    1. Soriano JB. The GOLD Rush. Thorax.2013;68(10): 902–903. 10.1136/thoraxjnl-2013-203595
    1. Soriano JB, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluna JJ, et al. Distribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classification. Chest.2013;143(3): 694–702.
    1. Soriano JB, Lamprecht B, Ramirez AS, Martinez-Camblor P, Kaiser B, Alfageme I, et al. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir Med.2015;3(6): 443–450. 10.1016/S2213-2600(15)00157-5
    1. Gimeno-Santos E, Frei A, Steurer-Stey C, de BJ, Rabinovich RA, Raste Y, et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax.2014;69(8): 731–739. 10.1136/thoraxjnl-2013-204763
    1. Vorrink SN, Kort HS, Troosters T, Lammers JW. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res.2011;12: 33 10.1186/1465-9921-12-33
    1. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med.2005;171(9): 972–977.
    1. Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, et al. Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med.2012;106(4): 522–530. 10.1016/j.rmed.2011.10.022
    1. Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J.2012;40(5): 1115–1122. 10.1183/09031936.00170111
    1. Van Remoortel H, Hornikx M, Demeyer H, Langer D, Burtin C, Decramer M, et al. Daily physical activity in subjects with newly diagnosed COPD. Thorax.2013;68(10): 962–963. 10.1136/thoraxjnl-2013-203534
    1. Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J.2013;42(3): 647–654. 10.1183/09031936.00125612
    1. Kim S, Oh J, Kim YI, Ban HJ, Kwon YS, Oh IJ, et al. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. Bmc Pulmonary Medicine.2013;13.
    1. Gimeno-Santos E, Raste Y, Demeyer H, Louvaris Z, de JC, Rabinovich RA, et al. The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease. Eur Respir J.2015;in press, 10.1183/09031936.00183014
    1. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J.2005;26(2): 319–338.
    1. Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J.2014;44(6): 1447–1478. 10.1183/09031936.00150414
    1. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung-Volumes and Forced Ventilatory Flows—Report Working Party Standardization of Lung-Function Tests European-Community for Steel and Coal—Official Statement of the European Respiratory Society. European Respiratory Journal.1993;6: 5–40.
    1. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. European Respiratory Journal.1999;14(2): 270–274.
    1. Rabinovich RA, Louvaris Z, Raste Y, Langer D, Remoortel HV, Giavedoni S, et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J.2013;42(5): 1205–1215. 10.1183/09031936.00134312
    1. Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, et al. Validity of Six Activity Monitors in Chronic Obstructive Pulmonary Disease: A Comparison with Indirect Calorimetry. Plos One.2012;7(6).
    1. Demeyer H, Burtin C, Van RH, Hornikx M, Langer D, Decramer M, et al. Standardizing the analysis of physical activity in patients with COPD following a pulmonary rehabilitation program. Chest.2014;146(2): 318–327. 10.1378/chest.13-1968
    1. Depew ZS, Novotny PJ, Benzo RP. How many steps are enough to avoid severe physical inactivity in patients with chronic obstructive pulmonary disease? Respirology.2012;17(6): 1026–1027. 10.1111/j.1440-1843.2012.02207.x
    1. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN. Development and first validation of the COPD Assessment Test. Eur Respir J.2009;34(3): 648–654. 10.1183/09031936.00102509
    1. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax.1999;54(7): 581–586.
    1. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes.2003;1: 13
    1. Kon S, Canavan J, Nolan C, Jones S, Clark A, Polkey M, et al. The Clinical Chronic Obstructive Pulmonary Disease Questionnaire: Cut point for GOLD 2013 classification. American Journal of Respiratory and Critical Care Medicine.2014;189(2).
    1. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med.2005;37(5): 360–363.
    1. Park SK, Meldrum CA, Larson JL. Subgroup analysis of symptoms and their effect on functioning, exercise capacity, and physical activity in patients with severe chronic obstructive pulmonary disease. Heart Lung.2013;42(6): 465–472. 10.1016/j.hrtlng.2013.08.008
    1. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest.2002;121(5): 1434–1440.
    1. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med.2012;186(10): 975–981. 10.1164/rccm.201207-1299OC
    1. Agusti A, Edwards LD, Celli B, Macnee W, Calverley PM, Mullerova H, et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J.2013;42(3): 636–646. 10.1183/09031936.00195212
    1. Van Remoortel H, Hornikx M, Langer D, Burtin C, Everaerts S, Verhamme P, et al. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Respir Crit Care Med.2014;189(1): 30–38. 10.1164/rccm.201307-1240OC
    1. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax.2006;61(9): 772–778.
    1. Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, et al. Differential effect of mMRC dyspnea, CAT and CCQ for symptom evaluation within the new GOLD staging and mortality in COPD. Chest.2015;148(1): 154–168.
    1. Agusti A, Hurd S, Jones P, Fabbri L, Martinez F, Vogelmeier C, et al. Frequently asked questions (FAQs) about the GOLD 2011 assessment proposal of COPD. Eur Respir J.2013;42(5): 1391–1401. 10.1183/09031936.00036513
    1. Moreira GL, Donaria L, Furlanetto KC, Paes T, Sant'Anna T, Hernandes NA, et al. GOLD B-C-D groups or GOLD II-III-IV grades: Which one better reflects the functionality of patients with chronic obstructive pulmonary disease? Chron Respir Dis.2015;12(2): 102–110. 10.1177/1479972315573528
    1. Boland MR, Tsiachristas A, Kruis AL, Chavannes NH, Rutten-van Molken MP. Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study. Prim Care Respir J.2014;23(1): 30–37. 10.4104/pcrj.2014.00002
    1. Durheim MT, Smith PJ, Babyak MA, Mabe SK, Martinu T, Welty-Wolf KE, et al. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group. Ann Am Thorac Soc.2015;12(3): 349–356. 10.1513/AnnalsATS.201408-365OC
    1. Garfield BE, Canavan JL, Smith CJ, Ingram KA, Fowler RP, Clark AL, et al. Stanford Seven-Day Physical Activity Recall questionnaire in COPD. Eur Respir J.2012;40(2): 356–362. 10.1183/09031936.00113611
    1. Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009; 33(2):262–272. 10.1183/09031936.00024608

Source: PubMed

3
S'abonner